Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of ...

We came across a bullish thesis on Alvotech (ALVO) on M.V Cunha’s Substack. In this article, we will summarize the bulls’ ...

REYKJAVIK, Iceland, June 26, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines ...

Potential Positives. Alvotech received a positive opinion from the EMA's CHMP, bringing the proposed biosimilar AVT06 closer to market approval in the European Economic Area.

Alvotech and Dr. Reddy’s have entered into a collaboration and license agreement to co-develop, manufacture and commercialize ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines ...

We came across a bullish thesis on Alvotech (ALVO) on M.V Cunha’s Substack. In this article, we will summarize the bulls’ thesis on ALVO. Alvotech (ALVO)’s share was trading at $10.37 as of ...

Alvotech disclaims any and all liability for any loss or damage (whether foreseeable or not) suffered or incurred by any person or entity as a result of anything contained or omitted from this ...

Alvotech (NASDAQ: ALVO, ALVO-SDB, the "Company"), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the completio ...

EMA committee recommends marketing approval of AVT06, Alvotech’s proposed biosimilar to Eylea: Reykjavik, Iceland Tuesday, June 24, 2025, 17:00 Hrs [IST] Alvotech, a global biot ...

Alvotech completed a private placement, raising funds from institutional investors, enhancing its shareholder base and SDR liquidity. Quiver AI Summary ...

Dr Reddy’s Laboratories announced that it has partnered with Alvotech, to co-develop, manufacture, and sell a biosimilar version of Keytruda (pembrolizumab), for global markets.